Likelihood for false positives using bacterially-expressed recombinant proteins in anti-angiogenesis studies.
Dudley
Andrew C
AC
Vascular Biology Program, Department of Surgery, Harvard Medical School, Boston, Massachusetts 02114, USA.
D020533:Angiogenesis Inhibitors / Q000494:pharmacology*; D000818:Animals; D001419:Bacteria / Q000378:metabolism; D002474:Cell-Free System; D004730:Endothelium, Vascular / Q000378:metabolism; D005189:False Positive Reactions; D006801:Humans; D007249:Inflammation; D008070:Lipopolysaccharides / Q000378:metabolism; D009130:Muscle, Smooth / Q000378:metabolism; D009154:Mutation; D011994:Recombinant Proteins / Q000737:chemistry*; D012107:Research Design
D020533:Angiogenesis Inhibitors; D008070:Lipopolysaccharides; D011994:Recombinant Proteins